Based in Australia, AtCor Medical provides a comprehensive range non-invasive technologies and related services for measuring central blood pressure and arterial stiffness. They offer SphygmoCor systems that are used in diagnosis, patient management, pharmaceutical clinical trials and for research.
SphygmoCor CPV systems are portable devices that provide central pressures assessment and measure the pulse wave velocity. These devices are upgraded with innovative features to offer CPV capabilities. They can also be modified with CPVH configuration that helps in testing the variability in the heart rate. These SphygmoCor systems also help in testing standing and valsalva manoeuvre. SphygmoCor technology which is incorporated in these systems measure the central blood pressure as it is very important in accessing effects due to anti-hypertension therapy and detecting risks such as heart attack and stroke.
The company offers the original SphygmoCor Vx systems as a substitute to SphygmoCor CPV systems, which are also capable of providing the pulse wave velocity. Apart from these, various key parameters including ascending aortic blood pressure, aortic pulse pressure, augmentation index and ejection duration can be derived from the waveform at the ascending aorta.